iSpecimen (ISPC) Stock Price

iSpecimen Price

NASDAQ·CLOSED
0.79
​
Market closed

Revenue at iSpecimen has contracted by 7.0% per year over the past 7 years to 1.92 M USD. iSpecimen's net margin stands at -546.5%, down from -99.2% several years earlier. Analysts set a median price target of 3.06 USD, implying 287.5% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

iSpecimen stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iSpecimen business model & stock analysis

iSpecimen, Inc. generates revenue through its iSpecimen Marketplace platform, which connects healthcare providers with biospecimens to researchers in biopharmaceutical, in vitro diagnostic (IVD), and government/academic sectors. The platform consolidates biospecimen procurement by offering a single online marketplace where healthcare supply partners provide de-identified healthcare data, enabling researchers to search, manage workflows, and access administrative tools. Biopharmaceutical companies, IVD firms, and academic institutions purchase access to the platform’s data and services to accelerate medical discovery and streamline procurement processes. The company’s functional areas—search, workflow, data, and administration and reporting—support these transactions through integrated administrative and compliance management for all users. The iSpecimen Marketplace platform serves biopharmaceutical companies, in vitro diagnostic (IVD) companies, and government/academic institutions by providing a centralized hub for biospecimen procurement. Healthcare providers supplying biospecimens use the platform to list their collections, while researchers from the target sectors access the data for their studies. The platform’s de-identified healthcare data, compiled from healthcare supply partners, is a key asset that drives transactions. Administrative and reporting functions within the platform streamline operations for both suppliers and researchers, reducing manual effort and improving compliance. iSpecimen, Inc. monetizes its platform by facilitating connections between biospecimen suppliers and researchers across biopharmaceutical, IVD, and academic sectors. The company’s revenue comes from transactions and services provided through the iSpecimen Marketplace, which includes search capabilities, workflow management, data access, and administrative support. Healthcare supply partners contribute de-identified healthcare data to the platform, which researchers use to identify and procure necessary biospecimens for medical research and development.

Frequently asked questions about iSpecimen

Analysts currently set an average price target of 3.06 USD for the iSpecimen stock (median: 3.06 USD), implying +287.5 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the iSpecimen stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the iSpecimen share trades at 0.70 EUR (0.79 USD).

The iSpecimen share (ISPC) is listed on 1 stock exchanges, including: NASDAQ (ISPC).

The revenue cannot currently be calculated for iSpecimen.

The profit cannot currently be calculated for iSpecimen.

The P/E ratio cannot be calculated for iSpecimen at the moment.

The P/S cannot be calculated for iSpecimen currently.

The Eulerpool Quality Score for iSpecimen is 2/10.

The ISIN of iSpecimen is US45032V2079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of iSpecimen is ISPC. The ticker symbol is used to trade iSpecimen shares on the stock exchange.

Fair ValueTerminal
0.66 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
25,587.73 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Jun 17, 2021
ISIN
US45032V2079
Cusip
45032V108
Market capitalization
7.72 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-312.41 %
Last updated Nov 5, 2026, 3:41 AM

iSpecimen Peer Group

iSpecimen Ticker

NASDAQ · ISPC

All fundamentals and in-depth analysis of iSpecimen

Our stock analysis for iSpecimen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of iSpecimen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.